{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T03:39:14Z","timestamp":1761709154645},"reference-count":91,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["La Presse M\u00e9dicale"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1016\/j.lpm.2015.10.015","type":"journal-article","created":{"date-parts":[[2015,12,24]],"date-time":"2015-12-24T10:01:27Z","timestamp":1450951287000},"page":"162-176","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Les vaccins contre le zona\u00a0: efficacit\u00e9, s\u00e9curit\u00e9, et rapport co\u00fbt\/b\u00e9n\u00e9fices"],"prefix":"10.1016","volume":"45","author":[{"given":"Nabila","family":"Ferahta","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Imene","family":"Achek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julie","family":"Dubourg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierre-Olivier","family":"Lang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"9544","key":"10.1016\/j.lpm.2015.10.015_bib0460","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1016\/S0140-6736(06)69561-5","article-title":"Varicella","volume":"368","author":"Heininger","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.lpm.2015.10.015_bib0465","doi-asserted-by":"crossref","first-page":"922","DOI":"10.7326\/0003-4819-130-11-199906010-00017","article-title":"Recent advances in varicella-zoster virus infection","volume":"130","author":"Cohen","year":"1999","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.lpm.2015.10.015_bib0470","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1086\/653605","article-title":"Zoster vaccine: current status and future prospects","volume":"51","author":"Oxman","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.lpm.2015.10.015_bib0475","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1093\/cid\/cis575","article-title":"Herpes zoster-related deaths in the United States: validity of death certificates and mortality rates, 1979-2007","volume":"55","author":"Mahamud","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.lpm.2015.10.015_bib0480","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.lpm.2008.05.019","article-title":"Le zona du sujet \u00e2g\u00e9","volume":"38","author":"Lang","year":"2009","journal-title":"Presse Med"},{"key":"10.1016\/j.lpm.2015.10.015_bib0485","first-page":"391","article-title":"Herpes zoster: the associated burden and its prevention","volume":"9","author":"Lang","year":"2011","journal-title":"Geriatr Psychol Neuropsychiatr Vieil"},{"key":"10.1016\/j.lpm.2015.10.015_bib0490","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.4065\/82.11.1341","article-title":"A population-based study of the incidence and complication rates of herpes zoster before zoster vaccine introduction","volume":"82","author":"Yawn","year":"2007","journal-title":"Mayo Clin Proc"},{"issue":"Suppl. 1","key":"10.1016\/j.lpm.2015.10.015_bib0495","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1086\/510206","article-title":"Recommendations for the management of herpes zoster","volume":"44","author":"Dworkin","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.lpm.2015.10.015_bib0500","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1086\/421942","article-title":"Acute pain in herpes zoster and its impact on health-related quality of life","volume":"39","author":"Katz","year":"2004","journal-title":"Clin Infect Dis"},{"issue":"12\u00a0Suppl. 8","key":"10.1016\/j.lpm.2015.10.015_bib0505","doi-asserted-by":"crossref","first-page":"S52","DOI":"10.1212\/WNL.45.12_Suppl_8.S52","article-title":"Herpes zoster and quality of life: a self-limited disease with severe impact","volume":"45","author":"Lydick","year":"1995","journal-title":"Neurology"},{"key":"10.1016\/j.lpm.2015.10.015_bib0510","first-page":"9","article-title":"The nature of herpes zoster: A long-term study and a new hypothesis","volume":"58","author":"Hope-Simpson","year":"1965","journal-title":"Proc R Soc Med"},{"key":"10.1016\/j.lpm.2015.10.015_bib0515","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1097\/00005792-198209000-00003","article-title":"Population-based study of herpes zoster and its sequelae","volume":"61","author":"Ragozzino","year":"1982","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.lpm.2015.10.015_bib0520","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1186\/1471-2334-13-170","article-title":"Similar herpes zoster incidence across Europe: results from a systematic literature review","volume":"13","author":"Pinchinat","year":"2013","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.lpm.2015.10.015_bib0525","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1186\/1471-2334-10-230","article-title":"Epidemiology and economic burden of herpes zoster and post-herpetic neuralgia in Italy: a retrospective, population-based study","volume":"10","author":"Gialloreti","year":"2010","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.lpm.2015.10.015_bib0530","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1016\/j.vaccine.2008.12.024","article-title":"Estimating the cost-effectiveness of vaccination against herpes zoster in England and Wales","volume":"27","author":"van Hoek","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.lpm.2015.10.015_bib0535","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/1471-2334-9-55","article-title":"Burden of herpes zoster requiring hospitalization in Spain during a seven-year period (1998-2004)","volume":"9","author":"Gil","year":"2009","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.lpm.2015.10.015_bib0540","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1056\/NEJMct066061","article-title":"Varicella-zoster vaccine for the prevention of herpes zoster","volume":"356","author":"Kimberlin","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.lpm.2015.10.015_bib0545","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1017\/S0950268801005921","article-title":"Epidemiology of varicella zoster virus infection in Canada and the United Kingdom","volume":"127","author":"Brisson","year":"2001","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.lpm.2015.10.015_bib0550","article-title":"Recommandations pour le traitement et la pr\u00e9vention du zona et desdouleurs associ\u00e9es chez la personne \u00e2g\u00e9e","author":"Lang","year":"2015","journal-title":"Rev Med Int"},{"key":"10.1016\/j.lpm.2015.10.015_bib0555","first-page":"200","article-title":"Le vaccin contre le zona\u00a0: vos questions et leurs r\u00e9ponses","volume":"15","author":"Lang","year":"2015","journal-title":"Neur Psychiatr Geriatr"},{"key":"10.1016\/j.lpm.2015.10.015_bib0560","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1086\/528696","article-title":"Varicella-zoster virus-specific immune responses in elderly recipients of a herpes zoster vaccine","volume":"197","author":"Levin","year":"2008","journal-title":"J Infect Dis"},{"key":"10.1016\/j.lpm.2015.10.015_bib0565","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1093\/infdis\/jit342","article-title":"Varicella-zoster virus-specific antibody responses in 50-59-year-old recipients of zoster vaccine","volume":"208","author":"Levin","year":"2013","journal-title":"J Infect Dis"},{"issue":"Suppl. 2","key":"10.1016\/j.lpm.2015.10.015_bib0570","doi-asserted-by":"crossref","first-page":"S228","DOI":"10.1086\/522159","article-title":"Vaccination against Herpes Zoster and Postherpetic Neuralgia","volume":"197","author":"Oxman","year":"2008","journal-title":"J Infect Dis"},{"key":"10.1016\/j.lpm.2015.10.015_bib0575","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1056\/NEJMoa051016","article-title":"A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults","volume":"352","author":"Oxman","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.lpm.2015.10.015_bib0580","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1093\/cid\/cir970","article-title":"Efficacy, safety, and tolerability of herpes zoster vaccine in persons aged 50-59\u00a0years","volume":"54","author":"Schmader","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.lpm.2015.10.015_bib0585","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1016\/j.vaccine.2015.01.085","article-title":"The immunogenicity and safety of zoster vaccine in Taiwanese adults","volume":"33","author":"Yao","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.lpm.2015.10.015_bib0590","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1093\/infdis\/jis334","article-title":"Herpes zoster vaccine and the incidence of recurrent herpes zoster in an immunocompetent elderly population","volume":"206","author":"Tseng","year":"2012","journal-title":"J Infect Dis"},{"key":"10.1016\/j.lpm.2015.10.015_bib0595","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1093\/infdis\/jiv244","article-title":"Zoster Vaccine and the Risk of Postherpetic Neuralgia in Patients Who Developed Herpes Zoster Despite Having Received the Zoster Vaccine","volume":"212","author":"Tseng","year":"2015","journal-title":"J Infect Dis"},{"key":"10.1016\/j.lpm.2015.10.015_bib0600","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1111\/j.1365-2796.2011.02474.x","article-title":"Safety of zoster vaccine in adults from a large managed-care cohort: a Vaccine Safety Datalink study","volume":"271","author":"Tseng","year":"2012","journal-title":"J Intern Med"},{"key":"10.1016\/j.lpm.2015.10.015_bib0605","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1001\/jama.2010.1983","article-title":"Herpes zoster vaccine in older adults and the risk of subsequent herpes zoster disease","volume":"305","author":"Tseng","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.lpm.2015.10.015_bib0610","doi-asserted-by":"crossref","first-page":"3628","DOI":"10.1016\/j.vaccine.2011.03.018","article-title":"Evaluation of the incidence of herpes zoster after concomitant administration of zoster vaccine and polysaccharide pneumococcal vaccine","volume":"29","author":"Tseng","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.lpm.2015.10.015_bib0615","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1093\/infdis\/170.3.522","article-title":"Immune responses of elderly persons 4\u00a0years after receiving a live attenuated varicella vaccine","volume":"170","author":"Levin","year":"1994","journal-title":"J Infect Dis"},{"key":"10.1016\/j.lpm.2015.10.015_bib0620","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1086\/379048","article-title":"Decline in varicella-zoster virus (VZV)-specific cell-mediated immunity with increasing age and boosting with a high-dose VZV vaccine","volume":"188","author":"Levin","year":"2003","journal-title":"J Infect Dis"},{"key":"10.1016\/j.lpm.2015.10.015_bib0625","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1093\/cid\/cis638","article-title":"Persistence of the efficacy of zoster vaccine in the shingles prevention study and the short-term persistence substudy","volume":"55","author":"Schmader","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.lpm.2015.10.015_bib0630","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1093\/cid\/ciu918","article-title":"Long-term persistence of zoster vaccine efficacy","volume":"60","author":"Morrison","year":"2015","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.lpm.2015.10.015_bib0635","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.4161\/hv.7.11.17982","article-title":"Safety and tolerability of zoster vaccine in adults >\/=60\u00a0years old","volume":"7","author":"Murray","year":"2011","journal-title":"Hum Vaccin"},{"key":"10.1016\/j.lpm.2015.10.015_bib0640","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.4161\/hv.7.10.16480","article-title":"Immunogenicity and safety of ZOSTAVAX\u00ae approaching expiry potency in individuals aged >\/=50\u00a0years","volume":"7","author":"Arnou","year":"2011","journal-title":"Hum Vaccin"},{"key":"10.1016\/j.lpm.2015.10.015_bib0645","doi-asserted-by":"crossref","first-page":"6636","DOI":"10.1016\/j.vaccine.2012.08.070","article-title":"Safety of Zostavax--a cohort study in a managed care organization","volume":"30","author":"Baxter","year":"2012","journal-title":"Vaccine"},{"issue":"Suppl. 1","key":"10.1016\/j.lpm.2015.10.015_bib0650","doi-asserted-by":"crossref","first-page":"S99","DOI":"10.1086\/514265","article-title":"A dose-response study of a live attenuated varicella-zoster virus (Oka strain) vaccine administered to adults 55\u00a0years of age and older","volume":"178","author":"Berger","year":"1998","journal-title":"J Infect Dis"},{"key":"10.1016\/j.lpm.2015.10.015_bib0655","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.vaccine.2014.12.024","article-title":"Comparison of intramuscular and subcutaneous administration of a herpes zoster live-attenuated vaccine in adults aged >\/=50\u00a0years: a randomised non-inferiority clinical trial","volume":"33","author":"Diez-Domingo","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.lpm.2015.10.015_bib0660","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1128\/CVI.00310-07","article-title":"A double-blind, randomized, controlled, multicenter safety and immunogenicity study of a refrigerator-stable formulation of Zostavax","volume":"15","author":"Gilderman","year":"2008","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.lpm.2015.10.015_bib0665","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.3899\/jrheum.130170","article-title":"Herpes zoster vaccination in SLE: a pilot study of immunogenicity","volume":"40","author":"Guthridge","year":"2013","journal-title":"J Rheumatol"},{"key":"10.1016\/j.lpm.2015.10.015_bib0670","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.jinf.2013.04.010","article-title":"Safety, humoral and cell-mediated immune responses to herpes zoster vaccine in subjects with diabetes mellitus","volume":"67","author":"Hata","year":"2013","journal-title":"J Infect"},{"key":"10.1016\/j.lpm.2015.10.015_bib0675","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1093\/cid\/cis1208","article-title":"Varicella zoster virus-specific immune responses to a herpes zoster vaccine in elderly recipients with major depression and the impact of antidepressant medications","volume":"56","author":"Irwin","year":"2013","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.lpm.2015.10.015_bib0680","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.bbmt.2013.11.013","article-title":"Live attenuated varicella-zoster vaccine in hematopoietic stem cell transplantation recipients","volume":"20","author":"Issa","year":"2014","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.lpm.2015.10.015_bib0685","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1111\/j.1532-5415.2007.01397.x","article-title":"Safety and immunogenicity profile of the concomitant administration of ZOSTAVAX and inactivated influenza vaccine in adults aged 50\u00a0and older","volume":"55","author":"Kerzner","year":"2007","journal-title":"J Am Geriatr Soc"},{"issue":"4","key":"10.1016\/j.lpm.2015.10.015_bib0690","doi-asserted-by":"crossref","first-page":"e1001420","DOI":"10.1371\/journal.pmed.1001420","article-title":"Herpes zoster vaccine effectiveness against incident herpes zoster and post-herpetic neuralgia in an older US population: a cohort study","volume":"10","author":"Langan","year":"2013","journal-title":"PLoS Med"},{"key":"10.1016\/j.lpm.2015.10.015_bib0695","doi-asserted-by":"crossref","first-page":"894","DOI":"10.4161\/hv.6.11.12852","article-title":"Concomitant administration of zoster and pneumococcal vaccines in adults >\/=60\u00a0years old","volume":"6","author":"MacIntyre","year":"2010","journal-title":"Hum Vaccin"},{"key":"10.1016\/j.lpm.2015.10.015_bib0700","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1080\/21645515.2015.1016681","article-title":"Herpes zoster vaccine effectiveness and manifestations of herpes zoster and associated pain by vaccination status","volume":"11","author":"Marin","year":"2015","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.lpm.2015.10.015_bib0705","doi-asserted-by":"crossref","first-page":"4204","DOI":"10.1016\/j.vaccine.2010.04.003","article-title":"Safety, tolerability, and immunogenicity of zoster vaccine in subjects with a history of herpes zoster","volume":"28","author":"Mills","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.lpm.2015.10.015_bib0710","doi-asserted-by":"crossref","first-page":"3129","DOI":"10.1016\/j.vaccine.2015.04.090","article-title":"Safety, tolerability, and immunogenicity of zoster vaccine in subjects on chronic\/maintenance corticosteroids","volume":"33","author":"Russell","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.lpm.2015.10.015_bib0715","doi-asserted-by":"crossref","first-page":"545","DOI":"10.7326\/0003-4819-152-9-201005040-00004","article-title":"Safety of herpes zoster vaccine in the shingles prevention study: a randomized trial","volume":"152","author":"Simberkoff","year":"2010","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.lpm.2015.10.015_bib0720","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1128\/CVI.00407-08","article-title":"Comparison of the levels of immunogenicity and safety of Zostavax in adults 50\u00a0to 59\u00a0years old and in adults 60\u00a0years old or older","volume":"16","author":"Sutradhar","year":"2009","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.lpm.2015.10.015_bib0725","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1016\/j.vaccine.2006.10.027","article-title":"Safety and tolerability of a high-potency zoster vaccine in adults >\/= 50\u00a0or years of age","volume":"25","author":"Tyring","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.lpm.2015.10.015_bib0730","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/j.vaccine.2011.11.096","article-title":"Safety, tolerability, and immunogenicity after 1\u00a0and 2\u00a0doses of zoster vaccine in healthy adults >\/=60\u00a0years of age","volume":"30","author":"Vermeulen","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.lpm.2015.10.015_bib0735","doi-asserted-by":"crossref","first-page":"858","DOI":"10.4161\/hv.23412","article-title":"Immunogenicity and safety of a live attenuated shingles (herpes zoster) vaccine (Zostavax\u00ae) in individuals aged \u2265 70\u00a0years: a randomized study of a single dose vs. two different two-dose schedules","volume":"9","author":"Vesikari","year":"2013","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.lpm.2015.10.015_bib0740","doi-asserted-by":"crossref","first-page":"318","DOI":"10.4161\/hv.6.4.10654","article-title":"Safety and immunogenicity of a live attenuated varicella vaccine in VZV-seropositive HIV-infected adults","volume":"6","author":"Weinberg","year":"2010","journal-title":"Hum Vaccin"},{"issue":"5","key":"10.1016\/j.lpm.2015.10.015_bib0745","doi-asserted-by":"crossref","first-page":"R174","DOI":"10.1186\/ar3497","article-title":"The use, safety, and effectiveness of herpes zoster vaccination in individuals with inflammatory and autoimmune diseases: a longitudinal observational study","volume":"13","author":"Zhang","year":"2011","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.lpm.2015.10.015_bib0750","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1001\/jama.2012.7304","article-title":"Association between vaccination for herpes zoster and risk of herpes zoster infection among older patients with selected immune-mediated diseases","volume":"308","author":"Zhang","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.lpm.2015.10.015_bib0755","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1093\/cid\/ciu498","article-title":"Vaccination against zoster remains effective in older adults who later undergo chemotherapy","volume":"59","author":"Tseng","year":"2014","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.lpm.2015.10.015_bib0760","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1093\/infdis\/jit182","article-title":"Safety of zoster vaccine in elderly adults following documented herpes zoster","volume":"208","author":"Morrison","year":"2013","journal-title":"J Infect Dis"},{"key":"10.1016\/j.lpm.2015.10.015_bib0765","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1586\/14760584.2014.924403","article-title":"Vaccine responsiveness in the elderly: best practice for the clinic","volume":"13","author":"Aspinall","year":"2014","journal-title":"Expert Rev Vaccine"},{"key":"10.1016\/j.lpm.2015.10.015_bib0770","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1345\/aph.1R742","article-title":"Concomitant administration of pneumococcal-23\u00a0and zoster vaccines provides adequate herpes zoster coverage","volume":"47","author":"Wyman","year":"2013","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.lpm.2015.10.015_bib0775","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1093\/infdis\/jis497","article-title":"A phase 1\/2\u00a0clinical trial evaluating safety and immunogenicity of a varicella zoster glycoprotein e subunit vaccine candidate in young and older adults","volume":"206","author":"Leroux-Roels","year":"2012","journal-title":"J Infect Dis"},{"key":"10.1016\/j.lpm.2015.10.015_bib0780","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.4161\/hv.24269","article-title":"Safety and immunogenicity of an AS01-adjuvanted varicella zoster virus subunit candidate vaccine (HZ\/su): a phase-I, open-label study in Japanese adults","volume":"9","author":"Lal","year":"2013","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.lpm.2015.10.015_bib0785","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1093\/infdis\/jit365","article-title":"Safety and immunogenicity of an AS01-adjuvanted varicella-zoster virus subunit candidate vaccine against herpes zoster in adults >=50\u00a0years of age","volume":"208","author":"Chlibek","year":"2013","journal-title":"J Infect Dis"},{"key":"10.1016\/j.lpm.2015.10.015_bib0790","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1016\/j.vaccine.2014.01.019","article-title":"Safety and immunogenicity of three different formulations of an adjuvanted varicella-zoster virus subunit candidate vaccine in older adults: a phase II, randomized, controlled study","volume":"32","author":"Chlibek","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.lpm.2015.10.015_bib0795","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1093\/infdis\/jiu606","article-title":"Safety and immunogenicity of an adjuvanted herpes zoster subunit candidate vaccine in HIV-infected adults: a phase 1\/2a randomized, placebo-controlled study","volume":"211","author":"Berkowitz","year":"2015","journal-title":"J Infect Dis"},{"key":"10.1016\/j.lpm.2015.10.015_bib0800","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1056\/NEJMoa1501184","article-title":"Efficacy of an adjuvanted herpes zoster subunit vaccine in older adults","volume":"372","author":"Lal","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.lpm.2015.10.015_bib0805","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1093\/infdis\/jit344","article-title":"Safety and immunogenicity of heat-treated zoster vaccine (ZVHT) in immunocompromised adults","volume":"208","author":"Mullane","year":"2013","journal-title":"J Infect Dis"},{"key":"10.1016\/j.lpm.2015.10.015_bib0810","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1586\/erp.13.19","article-title":"Vaccination against herpes zoster and postherpetic neuralgia in France: a cost-effectiveness analysis","volume":"13","author":"Bresse","year":"2013","journal-title":"Expert Rev Pharmacoecon Outcomes Res"},{"key":"10.1016\/j.lpm.2015.10.015_bib0815","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1186\/1472-6963-13-359","article-title":"Health economic evaluation of vaccination strategies for the prevention of herpes zoster and postherpetic neuralgia in Germany","volume":"13","author":"Ultsch","year":"2013","journal-title":"BMC Health Serv Res"},{"key":"10.1016\/j.lpm.2015.10.015_bib0820","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1080\/21645515.2015.1011561","article-title":"Cost-effectiveness analysis of a vaccination program for the prevention of herpes zoster and post-herpetic neuralgia in adults aged 50\u00a0and over in Germany","volume":"11","author":"Pr\u00e9aud","year":"2015","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.lpm.2015.10.015_bib0825","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.vaccine.2011.10.036","article-title":"Cost-effectiveness of vaccination against herpes zoster in adults aged over 60\u00a0years in Belgium","volume":"30","author":"Bilcke","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.lpm.2015.10.015_bib0830","doi-asserted-by":"crossref","first-page":"537","DOI":"10.3111\/13696998.2010.502854","article-title":"Health economic evaluation of a vaccine for the prevention of herpes zoster (shingles) and post-herpetic neuralgia in adults in Belgium","volume":"13","author":"Annemans","year":"2010","journal-title":"J Med Econ"},{"key":"10.1016\/j.lpm.2015.10.015_bib0835","doi-asserted-by":"crossref","first-page":"991","DOI":"10.2165\/11314010-000000000-00000","article-title":"Cost effectiveness of herpes zoster vaccine in Canada","volume":"27","author":"Najafzadeh","year":"2009","journal-title":"Pharmacoeconomics"},{"key":"10.1016\/j.lpm.2015.10.015_bib0840","doi-asserted-by":"crossref","first-page":"238","DOI":"10.4161\/hv.4.3.5686","article-title":"The potential cost-effectiveness of vaccination against herpes zoster and post-herpetic neuralgia","volume":"4","author":"Brisson","year":"2008","journal-title":"Hum Vaccin"},{"key":"10.1016\/j.lpm.2015.10.015_bib0845","doi-asserted-by":"crossref","first-page":"317","DOI":"10.7326\/0003-4819-145-5-200609050-00004","article-title":"Cost-effectiveness of a vaccine to prevent herpes zoster and postherpetic neuralgia in older adults","volume":"145","author":"Hornberger","year":"2006","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.lpm.2015.10.015_bib0850","doi-asserted-by":"crossref","first-page":"8326","DOI":"10.1016\/j.vaccine.2007.09.066","article-title":"Evaluation of the cost-effectiveness in the United States of a vaccine to prevent herpes zoster and postherpetic neuralgia in older adults","volume":"25","author":"Pellissier","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.lpm.2015.10.015_bib0855","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1086\/514342","article-title":"Cost-effectiveness of a vaccine to prevent herpes zoster and postherpetic neuralgia in older adults","volume":"44","author":"Rothberg","year":"2007","journal-title":"Clin Infect Dis"},{"issue":"7","key":"10.1016\/j.lpm.2015.10.015_bib0860","doi-asserted-by":"crossref","first-page":"489","DOI":"10.7326\/M15-0093","article-title":"Cost-Effectiveness of Herpes Zoster Vaccine for Persons Aged 50\u00a0Years","volume":"163","author":"Le","year":"2015","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.lpm.2015.10.015_bib0865","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1016\/j.vaccine.2012.12.067","article-title":"Cost-effectiveness of vaccination of the elderly against herpes zoster in The Netherlands","volume":"31","author":"de Boer","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.lpm.2015.10.015_bib0870","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1186\/1472-6963-10-237","article-title":"Assessing the potential effects and cost-effectiveness of programmatic herpes zoster vaccination of elderly in the Netherlands","volume":"10","author":"van Lier","year":"2010","journal-title":"BMC Health Serv Res"},{"key":"10.1016\/j.lpm.2015.10.015_bib0875","doi-asserted-by":"crossref","first-page":"3076","DOI":"10.1016\/S0264-410X(01)00044-5","article-title":"The epidemiology of herpes zoster and potential cost-effectiveness of vaccination in England and Wales","volume":"19","author":"Edmunds","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.lpm.2015.10.015_bib0880","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1478-7547-8-7","article-title":"A health economic model for evaluating a vaccine for the prevention of herpes zoster and post-herpetic neuralgia in the UK","volume":"8","author":"Moore","year":"2010","journal-title":"Cost Eff Resour Alloc"},{"key":"10.1016\/j.lpm.2015.10.015_bib0885","doi-asserted-by":"crossref","first-page":"749","DOI":"10.4161\/hv.7.7.15573","article-title":"Economic evaluation of a vaccine for the prevention of herpes zoster and post-herpetic neuralgia in older adults in Switzerland","volume":"7","author":"Szucs","year":"2011","journal-title":"Hum Vaccin"},{"key":"10.1016\/j.lpm.2015.10.015_bib0890","doi-asserted-by":"crossref","first-page":"812","DOI":"10.4161\/hv.23334","article-title":"Childhood varicella-zoster virus vaccination in Belgium: cost-effective only in the long run or without exogenous boosting?","volume":"9","author":"Bilcke","year":"2013","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.lpm.2015.10.015_bib0895","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1016\/j.vaccine.2011.11.026","article-title":"The cost-effectiveness of varicella and combined varicella and herpes zoster vaccination programmes in the United Kingdom","volume":"30","author":"van Hoek","year":"2012","journal-title":"Vaccine"},{"issue":"Suppl. 2","key":"10.1016\/j.lpm.2015.10.015_bib0900","doi-asserted-by":"crossref","first-page":"S216","DOI":"10.1086\/522153","article-title":"National survey of primary care physicians regarding herpes zoster and the herpes zoster vaccine","volume":"197","author":"Hurley","year":"2008","journal-title":"J Infect Dis"},{"key":"10.1016\/j.lpm.2015.10.015_bib0905","doi-asserted-by":"crossref","first-page":"555","DOI":"10.7326\/0003-4819-152-9-201005040-00005","article-title":"Barriers to the use of herpes zoster vaccine","volume":"152","author":"Hurley","year":"2010","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.lpm.2015.10.015_bib0455","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.vaccine.2008.10.047","article-title":"Determinants of non-compliance with herpes zoster vaccination in the community-dwelling elderly","volume":"27","author":"Opstelten","year":"2009","journal-title":"Vaccine"}],"container-title":["La Presse M\u00e9dicale"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0755498215004777?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0755498215004777?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,2]],"date-time":"2019-09-02T19:11:51Z","timestamp":1567451511000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0755498215004777"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2]]},"references-count":91,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,2]]}},"alternative-id":["S0755498215004777"],"URL":"https:\/\/doi.org\/10.1016\/j.lpm.2015.10.015","relation":{},"ISSN":["0755-4982"],"issn-type":[{"value":"0755-4982","type":"print"}],"subject":[],"published":{"date-parts":[[2016,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Les vaccins contre le zona\u00a0: efficacit\u00e9, s\u00e9curit\u00e9, et rapport co\u00fbt\/b\u00e9n\u00e9fices","name":"articletitle","label":"Article Title"},{"value":"La Presse M\u00e9dicale","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lpm.2015.10.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}